Download PDF
Thromb Haemost 1996; 76(06): 0860-0866
DOI: 10.1055/s-0038-1650676
Rapid Communication
Schattauer GmbH Stuttgart

Biological Consequences of Thrombin Receptor Deficiency in Mice

Andrew L Darrow
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
,
Wai-Ping Fung-Leung
2   The R. W. Johnson Pharmaceutical Research Institute, San Diego, CA, USA
,
Richard D Ye
3   The Department of Immunology, Scripps Research Institute, La Jolla, CA, USA
,
Rosemary J Santulli
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
,
Wai-Man Cheung
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
,
Claudia K Derian
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
,
Carol L Burns
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
,
Bruce P Damiano
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
,
Lubing Zhou
2   The R. W. Johnson Pharmaceutical Research Institute, San Diego, CA, USA
,
Charlotte M Keenan
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
,
Per A Peterson
2   The R. W. Johnson Pharmaceutical Research Institute, San Diego, CA, USA
,
Patricia Andrade-Gordon
1   The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
› Author Affiliations
Further Information

Publication History

Received 26 August 1996

Accepted after resubmission 08 October 1996

Publication Date:
11 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The thrombin receptor (ThrR) is a membrane-bound, G-protein-coupled receptor for the serine protease thrombin. This receptor is expressed in a wide variety of cells and tissues, and elicits a range of physiological responses associated with tissue injury, inflammation, and wound repair. To achieve a better understanding of the physiological role of the ThrR, we have employed homologous recombination to create mice with a disrupted ThrR gene. Following heterozygous (+/-) intercrosses, a total of 351 surviving offspring were genotyped. Only 7% of these offspring were identified as homozygous (-/-) for the disrupted allele, indicating a profound effect on embryonic development. Paradoxically, adult ThrR-/- mice appeared to be normal by anatomical and histological analysis, including their platelet number and function. Similarly, ThrR deficiency had no detectable effect in adult ThrR-/- mice on basal heart rate, arterial blood pressure, vasomotor responses to angiotensin II and acetylcholine, and coagulation parameters, even though the ThrR is expressed in many cardiovascular tissue types. In addition, the loss of ThrR function in the peripheral vasculature of adult ThrR-/- mice was confirmed by the absence of various standard hemodynamic effects of the ThrR-activating peptides SFLLRN-NH2 and TFLLRNPNDK-NH2 Our results indicate that ThrR deficiency has a strong impact on fetal development; however, ThrR-/- mice that proceed to full development display surprisingly little change in phenotype compared to the wild-type

 

  • References

  • 1 Vu T-KH, Wheaton VI, Hung DT, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism. Cell 1991; 64: 1057-1068
    CrossrefPubMedGoogle Scholar
  • 2 Coughlin SR. Thrombin receptor structure and function. Thromb Haemost 1993; 66: 184-187
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Patho 1994; 144: 975-985
    PubMedGoogle Scholar
  • 4 Grandaliano G, Valente AJ, Abboud HE. A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. J Exp Med 1994; 179: 1737-1741
    CrossrefPubMedGoogle Scholar
  • 5 Sugama Y, Malik AB. Thrombin receptor 14-amino acid peptide mediates endothelial hyperadhesivity and neutrophil adhesion by P-selectin-dependent mechanism. Circ Res 1992; 71: 1015-1019
    CrossrefPubMedGoogle Scholar
  • 6 Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA, Runge M. Characterization of thrombin receptor expression during vascular lesion formation. Circ Res 1994; 7: 1029-1038
    PubMedGoogle Scholar
  • 7 Wojtukiewcz MZ, Tang DG, Ben-Josef E, Renaud C, Walz DA, Honn KV. Solid tumor cells express functional “tethered ligand” thrombin receptor. Cancer Res 1995; 55: 698-704
    PubMedGoogle Scholar
  • 8 Nierodzik MLR, Bain RM, Liu LX, Shivji M, Takeshita K, Karpatkin S. Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumour tyrosine phosphorylation. Brit J Haematol 1996; 92: 452-457
    CrossrefPubMedGoogle Scholar
  • 9 Cunningham DD, Pulliam L, Vaughan PJ. Protease nexin-1 and thrombin: injury-related processes in the brain. Thromb Haemost 1993; 70: 168-171
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Ngaiza JR, Jaffe EA. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells. Biochem BiophysRes Commun 1991; 179: 1656-1661
    PubMedGoogle Scholar
  • 11 Garcia JGN, Patterson C, Bahler C, Aschner J, Hart CM, English D. Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J Cell Physiol 1993; 156: 541-549
    CrossrefPubMedGoogle Scholar
  • 12 Lum H, Andersen TT, Siflinger-Bimboim A, Tiruppathi C, Goligorsky MS, Fenton II JW, Malik AB. Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization. J Cell Biol 1993; 120: 1491-1499
    CrossrefPubMedGoogle Scholar
  • 13 Tesfamariam B, Allen GT, Normandin D, Antonaccio MJ. Involvement of the “tethered ligand” receptor in thrombin-induced endothelium-mediated relaxations. Am J Physiol 1993; 265: H1744-H1749
    PubMedGoogle Scholar
  • 14 Ku DD, Zaleski JK. Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs. J Cardiovasc Pharmacol 1993; 22: 609-616
    CrossrefPubMedGoogle Scholar
  • 15 Muramatsu I, Laniyonu A, Moore GJ, Hollenberg MD. Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol 1992; 70: 996-1003
    CrossrefPubMedGoogle Scholar
  • 16 Ku DD. Unmasking of thrombin vasoconstriction in isolated perfused dog hearts after intracoronary infusion of air embolus. J Pharmacol Exp Therap 1987; 243: 571-576
    PubMedGoogle Scholar
  • 17 Damiano BP, Mitchell JA, Cheung WM, Falotico R. Activation of vascular thrombin receptors mediates cardiac response to alpha-thrombin in isolated, perfused guinea pig heart. Amer J Physiol-Heart Circ Phy 1996; 39: H1585-H1596
    PubMedGoogle Scholar
  • 18 Damiano B, Cheung W, Mitchell J, Falotico R. Cardiovascular actions of thrombin receptor activation in vivo. J Pharmacol Exp Ther 1996 (in press)
    PubMedGoogle Scholar
  • 19 Connolly AJ, Ishihara H, Kahn ML, Farese Jr RV, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature (London) 1996; 381: 516-519
    CrossrefPubMedGoogle Scholar
  • 20 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Lab Press; Plainview, NY, 2nd ed: 1989
  • 21 Tybulewicz VLJ, Crawford CE, Jackson PK, Bronson RT, Mulligan RC. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 1991; 65: 1153-1163
    CrossrefPubMedGoogle Scholar
  • 22 Hooper M, Hardy K, Handyside A, Hunter S, Monk M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature (London) 1987; 326: 292-295
    CrossrefPubMedGoogle Scholar
  • 23 Fung-Leung W-P, Kundig TM, Ngo K, Panakos J, De Sousa-Hitzler J, Wang E, Ohashi PS, Mak TW, Lau CY. Reduced thymic maturation but normal effector function of CD8+ T cells in CD8 beta gene-targeted mice. J Exp Med 1994; 180: 959-967
    CrossrefPubMedGoogle Scholar
  • 24 Santulli RJ, Derian CK, Darrow AL, Tomko KA, Eckardt AJ, Seiberg M, Scarborough RM, Andrade-Gordon P. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci USA 1995; 92: 9151-9155
    CrossrefPubMedGoogle Scholar
  • 25 Ingerman-Wojenski C, Smith BB, Silver MJ. Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP, and accumulation of radiolabeled platelets. J Lab Clin Med 1983; 101: 44-52
    PubMedGoogle Scholar
  • 26 Connolly TM, Condra C, Feng D-M, Cook JJ, Stranieri MT, Reilly CF, Nutt RF, Gould RJ. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb Haemost 1994; 70: 627-633
    PubMedGoogle Scholar
  • 27 Derian CK, Santulli RJ, Tomko KA, Haertlein BJ, Andrade-Gordon P. Species differences in platelet responses to thrombin and SFLLRN-NH2 receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb Res 1995; 78: 505-519
    CrossrefPubMedGoogle Scholar
  • 28 Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential protease activated receptor. Proc Natl Acad Sci USA 1994; 91: 9208-9212
    CrossrefPubMedGoogle Scholar
  • 29 Blackhart BD, Emilsson K, Nguyent D, Teng W, Martelli AJ, Nystedt S, Sundelin J, Scarborough RM. Ligand cross-reactivity within the Protease-activated Receptor Family. J Biol Chem 1996; 271: 16466-16471
    CrossrefPubMedGoogle Scholar
  • 30 Lemer DJ, Chen M, Tram T, Coughlin SR. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor - importance of extracellular loop interactions for receptor function. J Biol Chem 1996; 271: 13943-13947
    CrossrefPubMedGoogle Scholar
  • 31 Al-Ani B, Saifeddine M, Hollenberg MD. Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 1995; 73: 1203-1207
    CrossrefPubMedGoogle Scholar
  • 32 Yamamoto N, Greco NJ, Barnard MR, Tanoue K, Yamazaki H, Jamieson GA, Michelson AD. Glycoprotein lb (GPIb)-dependent and GPIb-indepen-dent pathways of thrombin-induced platelet activation. Blood 1991; 77: 1740-1748
    PubMedGoogle Scholar
  • 33 De Marco L, Mazzucato M, Masotti A, Fenton JW, Ruggeri ZM. Function of glycoprotein Iba in platelet activation induced by a-thrombin. J Biol Chem 1991; 266: 23776-23783
    PubMedGoogle Scholar
  • 34 Janssens WJ, Verhaeghe RH. Effect of thrombin on isolated canine blood vessels. Blood Vessels 1982; 19: 126-134
    PubMedGoogle Scholar
  • 35 White RP, Shirasawa Y, Robertson JT. Comparison of responses elicited by alpha-thrombin in isolated canine basilar, coronary, mesenteric, and renal arteries. Blood Vessels 1984; 21: 12-22
    PubMedGoogle Scholar
  • 36 Walz DA, Anderson GF, Ciaglowski RE, Aiken M, Fenton II JW. Thrombin-elicited contractile responses of aortic smooth muscle. Proc Soc Exp Biol Med 1985; 180: 518-526
    CrossrefPubMedGoogle Scholar
  • 37 Kessels H, Willems G, Hemker HC. Analysis of thrombin generation in plasma. ComputBiol Med 1994; 24: 277-288
    PubMedGoogle Scholar
  • 38 Shuman MA, Majerus PW. The measurement of thrombin in clotting blood by radioimmunoassay. J Clin Invest 1976; 58: 1249-1258
    CrossrefPubMedGoogle Scholar
  • 39 Nelken NA, Soifer SJ, O’Keefe J, Vu TH, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 1992; 90: 1614-1621
    CrossrefPubMedGoogle Scholar